Increased invasive pneumococcal disease, North East England, UK

Emerging Infectious Diseases

Volumn 23, Issue 1, 2017, Pages 122-126

  Houseman, Catherine ^a   Hughes, Gareth J ^a   Chapman, Kaye E ^a   Wilson, Deborah ^a   Gorton, Russell ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; 23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE;

ARTICLE; DISEASE SURVEILLANCE; ENGLAND; HEALTH CARE PLANNING; HEALTH SURVEY; HUMAN; MORBIDITY; PNEUMOCOCCAL INFECTION; PREVALENCE; PUBLIC HEALTH; TREND STUDY; ADOLESCENT; ADULT; AGED; CHILD; CLASSIFICATION; EPIDEMIOLOGICAL MONITORING; FEMALE; GENETICS; IMMUNOLOGY; INCIDENCE; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; SEROTYPE; STATISTICS AND NUMERICAL DATA; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; VACCINATION; VIROLOGY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROGROUP; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; VACCINATION;

EID: 85006459312     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2301.160897     Document Type: Article

References (15)

1. Department of Health. Immunisation against infectious disease. The Green Book. 2012;25:295-313 [cited 2016 May 31]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/147832/Green-Book-updated-140313.pdf
2. Health and Social Care Information Centre. NHS Immunisation Statistics, England: 2014-2015 [cited 2016 Jul 19]. http://www.hscic.gov.uk/catalogue/PUB18472
3. Public Health England. Pneumococcal polysaccharide vaccine (PPV): vaccine coverage estimates [cited 2016 Jul 19]. https://www.gov.uk/government/publications/pneumococcal-polysaccharide-vaccine-ppv-vaccine-coverage-estimates
4. Chapman KE, Wilson D, Gorton R. Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England. Epidemiol Infect. 2013;141:344-52. http://dx.doi.org/10.1017/S0950268812000763
5. Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;15:535-43. http://dx.doi.org/10.1016/S1473-3099(15)70044-7
6. Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjöström K, et al. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Eur Respir J. 2016;47:1208-18. http://dx.doi.org/10.1183/ 13993003.01451-2015
7. Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15:301-9. http://dx.doi.org/10.1016/S1473-3099(14)71081-3
8. De Wals P, Lefebvre B, Markowski F, Deceuninck G, Defay F, Douville-Fradet M, et al. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine. 2014;32:1501-6. http://dx.doi.org/10.1016/j.vaccine.2013.11.028
9. Hughes GJ, Wright LB, Chapman KE, Wilson D, Gorton R. Serotype-specific differences in short-and longer-term mortality following invasive pneumococcal disease. Epidemiol Infect 2016;144:2654-69. http://dx.doi.org/10.1017/S0950268816000856
10. Office for National Statistics. Annual mid-year population estimates: 2014 [cited 2015 May 3]. https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/annualmidyearpopulationestimates/2015-06-25
11. Kuster SP, Tuite AR, Kwong JC, McGeer A, Fisman DN; Toronto Invasive Bacterial Diseases Network Investigators. Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance. PLoS Med. 2011;8:e1001042. http://dx.doi.org/10.1371/journal.pmed.1001042
12. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis. 2010;202:1287-95. http://dx.doi.org/10.1086/656333
13. Pebody R, Warburton F, Andrews N, Ellis J, von Wissmann B, Robertson C, et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results. Euro Surveill. 2015;20:30013. http://dx.doi.org/10.2807/1560-7917. ES.2015.20.36.30013
14. Wyres KL, Lambertsen LM, Croucher NJ, McGee L, von Gottberg A, Liñares J, et al. Pneumococcal capsular switching: a historical perspective. J Infect Dis. 2013;207:439-49. http://dx.doi.org/10.1093/infdis/jis703
15. Public Health England. Pneumococcal disease: guidance, data and analysis [cited 2016 May 31] https://www.gov.uk/government/ collections/pneumococcal-disease-guidance-data-and-analysis